QIAGEN launches complete Sample to Insight workflow for microbiome research

QIAGEN announced the launch of the Microbiome WGS SeqSets, a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maxi...

November 07, 2023 | Tuesday | News
Africa CDC Director General Visits SK bioscience to Discuss Vaccine Localization in Africa

H.E Dr. Jean Kaseya, Director General of the African Centers for Disease Control and Prevention (Africa CDC), visited SK bioscience t...

November 06, 2023 | Monday | News
Boehringer Ingelheim Hits Milestone in CKD: Promising Phase II Results with Aldosterone Synthase Inhibitor + Empagliflozin

Phase II results demonstrated significant albuminuria reductions by up to 39.5% vs. placebo when BI 690517, a novel selective aldosterone synthase inhibi...

November 06, 2023 | Monday | News
MoonLake Immunotherapeutics Reveals Breakthrough Phase 2 Results for Nanobody® Sonelokimab in Psoriatic Arthritis

First placebo-controlled randomized trial in active psoriatic arthritis (PsA) using a Nanobody® to report positive topline results in support of pote...

November 06, 2023 | Monday | News
Pfizer Advances GLP-1 Receptor Agonist PF-06954522 to Phase 1 Trial with Sosei Heptares Collaboration

Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) has been notified by Pfizer that it has entered a new oral s...

November 06, 2023 | Monday | News
Shuttle Pharma Advances Prostate Cancer Biomarker Program via Exclusive License

The intellectual property was originally developed through a collaboration of Shuttle Pharma scientists with investigators from Georgetown University. The ...

November 02, 2023 | Thursday | News
Twist Bioscience Introduces Dual Index Adapters for PCR-free Whole Genome Sequencing

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing and methylation detection Enables multiplexing and...

November 02, 2023 | Thursday | News
Singapore's Engine Biosciences Secures $27M in Series A Extension for Precision Oncology Development and Biomarker Research

Funds to support translation of R&D programs derived from proprietary NetMAPPR machine learning network biology platform and CombiGEM combinatorial gen...

November 02, 2023 | Thursday | News
Specialists Outline Strategy for Affordable and Accessible Cancer Care in India

  The FICCI (Federation of Indian Chambers of Commerce and Industry) on the opening day, 26th October, of its 17th annual healthcare confer...

October 30, 2023 | Monday | News
Renaissance BioScience Achieves Groundbreaking RNA Tech Patent

Renaissance BioScience Corp., a leader in bioengineering for the global agriculture, animal health, human medicine, and food industries, is pleased to anno...

October 30, 2023 | Monday | News
Fuelling Growth through Quality: A Candid Conversation with Lars Petersen, President and CEO of FUJIFILM Diosynth Biotechnologies, Unveiling the Key Role of Maja Pedersen

In the bustling halls of CPHI Barcelona, BioPharma BoardRoom had the privilege to sit down with Lars Petersen, the President and CEO of FUJIFILM Diosynth B...

October 27, 2023 | Friday | Interaction
Promega Study Reveals Ineffectiveness of Two NLRP3 Inhibitors in Live Cells

A new study uses key Promega technologies to evaluate reported anti-inflammation molecules in the context of live cells. Promega research scientists used t...

October 26, 2023 | Thursday | News
Accenture Acquires ConcentricLife to Strengthen Healthcare Marketing in Life Sciences

Founded in 2002, ConcentricLife is recognized as one of the MM+M Agency 100, the industry's definitive guide to the top agencies in the health landscape. I...

October 26, 2023 | Thursday | News
Zydus India Receives USFDA Approval for ZITUVIO™ to Treat Type 2 Diabetes.

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug Administra...

October 23, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close